Digital Health, Artificial Intelligence & Internet of Everything
We empower clients to capitalize on Digital Health, AI, and IoE - accelerating success in these emerging fields. Leveraging robust research capabilities, we deliver strategic insights enabling partners to build winning solutions and gain a competitive edge.
We empower Pharma, Biotech, Healthcare and HealthTech/MedTech companies to capitalize on Digital Health, AI and IoE, accelerating their competitive advantage.
As trusted partners, we provide strategic support spanning areas such as:
- Collaborative projects with BioPharma innovation units and patient solution teams
- Intensive patient-centricity research, placing the end-user at the heart of every solution
- Trend analysis in AI, wearable tech, digital therapeutics, and comprehensive digital health solutions
- Creation and support in AI-powered tool development for enhanced data intelligence
- Joint strategy formulation for competitive digital health and AI initiatives
- Pioneering research on the transformative impact of AI/IoE on healthcare, from “smart” homes to “smart” appliances
With robust research and consulting, we deliver evidence-based solutions, enabling clients to implement winning digital strategies.
Ready to accelerate innovation?
Let’s build winning tech strategies together. Contact us at info@lqventures.com.
October 28, 2025
Obesity Today — October 28, 2025
October 28, 2025
Lucid Diligence Brief: Guardant Health and Zephyr AI partnership
October 28, 2025
Obesity Video Recap — October 28, 2025
October 27, 2025
Hematology Today — October 27, 2025
October 27, 2025
Oncology Video Recap — October 27, 2025
October 27, 2025
Oncology Today — October 27, 2025
October 27, 2025
AI in Healthcare and Digital Health Today—October 27, 2025
October 27, 2025
Lucid Diligence Brief: Novartis to acquire Avidity Biosciences
October 26, 2025
Lucid Diligence Brief: ENA Respiratory Series B for Intranasal INNA-051
October 25, 2025
Lucid Diligence Brief: Lilly to acquire Adverum Biotechnologies
October 24, 2025
Lucid Diligence Brief: Wa’ed Ventures Kure Cells pre-Series A
October 24, 2025